NATCOPHARM.BONATCOPHARM.BOBSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+53.6%
5Y CAGR+9.7%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+53.6%/yr
vs -25.1%/yr prior
5Y CAGR
+9.7%/yr
Recent acceleration
Acceleration
+78.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 48.38% | +10.6% |
| 2024 | 43.74% | +22.5% |
| 2023 | 35.70% | +167.2% |
| 2022 | 13.36% | -54.7% |
| 2021 | 29.50% | -3.0% |
| 2020 | 30.40% | -19.9% |
| 2019 | 37.94% | -10.5% |
| 2018 | 42.42% | +25.2% |
| 2017 | 33.87% | +31.5% |
| 2016 | 25.75% | - |